Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention

Current Opinion in Cardiology

Volumn 28, Issue 5, 2013, Pages 547-553

  Ehrenthal, Deborah B ^a,b   Catov, Janet M ^c  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

adverse pregnancy outcomes; cardiovascular prevention; healthcare delivery

Indexed keywords

CHOLESTEROL;

AGE DISTRIBUTION; ATHEROSCLEROSIS; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COST EFFECTIVENESS ANALYSIS; COUNSELING; DELIVERY; DIABETES MELLITUS; GLUCOSE METABOLISM; GYNECOLOGIST; HIGH RISK POPULATION; HUMAN; HYPERANDROGENISM; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE; LIPID ANALYSIS; LONGITUDINAL STUDY; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SMALL FOR DATE INFANT; SMOKING; SOCIOECONOMICS; SUBFERTILITY;

AGE FACTORS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GYNECOLOGY; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; OBSTETRICS; PREGNANCY; RISK FACTORS; SEX FACTORS;

EID: 84883356236     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328364298e     Document Type: Review

References (45)

1. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012; 366:54-63.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127:e6-e245.
3. Bambs C, Kip KE, Dinga A, et al. Low prevalence of ''ideal cardiovascular health'' in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation 2011; 123:850-857.
4. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis. BMJ 2007; 335:974.
5. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156:918-930.
6. Rizzo M, Berneis K, Spinas G, et al.Long-termconsequences of polycystic ovary syndrome on cardiovascular risk. Fertil Steril 2009; 91 (4 Suppl):1563-1567.
7. Toulis KA, Goulis DG, Mintziori G, et al. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Hum Reprod Update 2011; 17:741-760.
8. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011; 123:1243-1262.
9. Lewis BG, Halm EA, Marcus SM, et al. Preventive services use among women seen by gynecologists, general medical physicians, or both. Obstet Gynecol 2008; 111:945-952.
10. Dong C, Rundek T, Wright CB, et al. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and Hispanics: the northern Manhattan study. Circulation 2012; 125:2975-2984.
11. Frierson GM, Howard EN, DeFina LE, et al. Effect of race and socioeconomic status on cardiovascular risk factor burden: the Cooper Center Longitudinal Study. Ethn Dis 2013; 23:35-42.
12. Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation 2012; 124:967-990.
13. Liu K, Daviglus ML, Loria CM, et al. Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study. Circulation 2012; 125:996-1004.
14. Berry JD, Dyer A, Cai X, et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012; 366:321-329.
15. Bateman BT, Shaw KM, Kuklina EV, et al. Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One 2012; 7:e36171.
16. Huffman MD, Capewell S, Ning H, et al. Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation 2012; 125:2595-2602.
17. Bonamy AK, Parikh NI, Cnattingius S, et al. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation 2011; 124:2839-2846.
18. Hastie CE, Smith GC, Mackay DF, Pell JP. Maternal risk of ischaemic heart disease following elective and spontaneous preterm delivery: retrospective cohort study of 750 350 singleton pregnancies. Int J Epidemiol 2011; 40:914-919.
19. Lin YS, Tang CH, Yang CY, et al. Effect of preeclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan. Am J Cardiol 2011; 107:325-330.
20. Drost JT, Arpaci G, Ottervanger JP, et al. Cardiovascular risk factors in women 10 years post early preeclampsia: the Preeclampsia Risk EValuation in FEMales study (PREVFEM). Eur J Prev Cardiol 2012; 19:1138-1144.
21. Wang IK, Tsai IJ, Chen PC, et al. Hypertensive disorders in pregnancy and subsequent diabetes mellitus: a retrospective cohort study. Am J Med 2012; 125:251-257.
22. Hermes W, Franx A, van Pampus MG, et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. Am J Obstet Gynecol 2013; 208:474.e1-e8.
23. Catov JM, Dodge R, Yamal JM, et al. Prior preterm or small-for- gestationalage birth related to maternal metabolic syndrome. Obstet Gynecol 2011; 117:225-232.
24. Catov JM, Lewis CE, Lee M, et al. Preterm birth and future maternal blood pressure, inflammation, and intimal-medial thickness: the CARDIA study. Hypertension 2013; 61:641-646.
25. Hastie CE, Smith GC, Mackay DF, Pell JP. Association between preterm delivery and subsequent C-reactive protein: a retrospective cohort study. Am J Obstet Gynecol 2011; 205:556e1-556e4.
26. Magnussen EB, Vatten LJ, Myklestad K, et al. Cardiovascular risk factors prior to conception and the length of pregnancy: population-based cohort study. Am J Obstet Gynecol 2011; 204:526 e1-526 e8.
27. McClure CK, Catov JM, Ness RB, Schwarz EB. Lactation and maternal subclinical cardiovascular disease among premenopausal women. Am J Obstet Gynecol 2012; 207:46 e1-46 e8.
28. Retnakaran R, Qi Y, Sermer M, et al. The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-h on the oral glucose tolerance test in pregnancy. Nutr Metab Cardiovasc Dis 2011; 21:706-712.
29. Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 2012; 125:1367-1380.
30. Rasmussen KM, Abrams B, Bodnar LM, et al. Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol 2009; 116:1191-1195.
31. Nehring I, Schmoll S, Beyerlein A, et al.Gestational weight gain and long-term postpartum weight retention: a meta-analysis. Am J Clin Nutr 2011; 94:1225-1231.
32. Fraser A, Tilling K, Macdonald-Wallis C, et al. Associations of gestational weight gain with maternal body mass index, waist circumference, and blood pressure measured 16 y after pregnancy: the Avon Longitudinal Study of Parents and Children (ALSPAC). Am J Clin Nutr 2011; 93:1285-1292.
33. Moghetti P, Tosi F, Bonin C, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab 2013; 98:E628-E637.
34. Parikh NI, Cnattingius S, Mittleman MA, et al. Subfertility and risk of later life maternal cardiovascular disease. Hum Reprod 2012; 27:568-575.
35. Clancy CM, Massion CT. American women's healthcare. A patchwork quilt with gaps. JAMA 1992; 268:1918-1920.
36. Bartman BA. Women's access to appropriate providers within managed care: implications for the quality of primary care. Womens Health Issues 1996; 6:45-50.
37. Schmittdiel J, Selby JV, Swain B, et al. Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension 2011; 57:717-722.
38. Kraschnewski JL, McCall-Hosenfeld JS, Weisman CS. Prospective association between body mass index and receipt of preventive services: results from the Central Pennsylvania Women's Health Study (CePAWHS). Prev Med 2012; 54:302-305.
39. Morgan MA, Lawrence H 3rd, Schulkin J. Obstetrician-gynecologists' approach to well woman care. Obstet Gynecol 2010; 116:715-722.
40. Ehrenthal DB, Nunez AE, O'Neill E, et al. The role of the obstetrician/ gynecologist in the prevention of cardiovascular disease in women. Womens Health Issues 2011; 21:338-344.
41. Keely E. An opportunity not to be missed-how do we improve postpartum screening rates for women with gestational diabetes? Diabetes Metab Res Rev 2012; 28:312-316.
42. Hunsberger ML, Donatelle RJ, Lindsay K, Rosenberg KD. Physician care patterns and adherence to postpartum glucose testing after gestational diabetes mellitus in Oregon. PLoS One 2012; 7:e47052.
43. Young B, Hacker MR, Rana S. Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy 2012; 31: 50-58.
44. Heidrich MB, Wenzel D, von Kaisenberg CS, et al. Preeclampsia and longterm risk of cardiovascular disease: what do obstetrician-gynecologists know? BMC Pregnancy Childbirth 2013; 13:61.
45. Rattan D, Mamun A, Najman JM, et al. Smoking behaviour in pregnancy and its impact on smoking cessation at various intervals during follow-up over 21 years: a prospective cohort study. BJOG 2013; 120:288-295; discussion 296.